Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details of a clinical trial involving the drug sacituzumab govitecan-hziy for participants with metastatic solid tumors.
    Difference
    0.1%
    Check dated 2024-06-06T14:23:43.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    15 days ago
    Change Detected
    Summary
    The value 'Primary Completion Date' (Estimated) has recently changed to '2024-06'. This change represents the updated estimated date for when the primary phase of the clinical study on sacituzumab govitecan in participants with metastatic solid tumors is expected to be completed.
    Difference
    0.0%
    Check dated 2024-05-25T04:04:57.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Summary
    The value 04 12 04 10 04 12 04 has been updated to 05 23 05 21 (Estimated) 05 23 05. This change likely represents an update in the estimated study completion date for the clinical trial involving the drug sacituzumab govitecan-hziy in participants with metastatic solid tumors.
    Difference
    0.7%
    Check dated 2024-05-24T03:17:43.000Z thumbnail image
  8. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria Collaborators' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing detailed inclusion and exclusion criteria for participants with specific types of metastatic or locally advanced solid tumors.
    Difference
    20%
    Check dated 2024-05-22T20:54:07.000Z thumbnail image
  9. Check
    39 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:26:47.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.